Hye‐Won Shin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hye‐Won Shin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Donald Ray Blake
Department of Chemistry University of California Irvine Irvine CA USA
3 shared publications - Brandon J Umber
Department of Chemistry, University of California, Irvine, CA 92697, USA
2 shared publications - Dan Michael Cooper
University of California
2 shared publications - Frank Zaldivar
Pediatric Exercise and Genomics Research Center, University of California Irvine, Irvine, CA, USA
2 shared publications - Simone Meinardi
University of California, Irvine
2 shared publications - Szu-Yun Leu
Department of Pediatrics, Institute for Clinical and Translational Science , University of California, Irvine , Irvine , California , USA
2 shared publications
Latest Publications
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Improvement of Knowledge and Research Attitudes on Preclinical Alzheimer’s Disease Trials through Community‐based Education Among Underrepresented Korean, Filipino, and Hispanic Americans
Background: Racial and ethnic minorities, including Hispanic/Latino, Asian American and Pacific Islander individuals, lack adequate representation in preclinical Alzheimer’s disease (AD) trials. This study sought to examine the effectiveness of a culturally and linguistically appropriate community‐based educational intervention in enhancing knowledge and awareness of the AHEAD 3‐45 preclinical AD trial among underrepresented Filipino, Korean, and Hispanic/Latino Americans.Method: With professional nursing and other partner organizations, we conducted 21 community‐based educational sessions for underrepresented older adults of Filipino, Korean, and Hispanic/Latino backgrounds. In addition to sociodemographic data, we collected the 7‐item Research Attitude Questionnaire (RAQ; Range 7‐35) and a 6‐item Knowledge Questionnaire about the AHEAD 3‐45 preclinical AD trial (Range 0‐6) before and after the educational intervention. Pre‐ and post‐summary scores were generated for both assessments. Paired t‐tests assessed changes in research attitudes and knowledge concerning the AHEAD 3‐45 trial.Result: Among 654 attendees of the educational interventions, 472 (72%) completed surveys (Table 1). Most were women (77%), immigrants (83%), and had a primary language other than English (70%). The average age was 59 (16) years. Survey responses were obtained in English (41%), Spanish (29%), and Korean (30%). The primary motivations reported by attendees for attending the event were gaining information (48%) and concerns about memory loss for self and/or family members (41%).Knowledge of the AHEAD 3‐45 preclinical AD trial was significantly increased from a mean of 2.15 (SD 2.2) at baseline to 4.32 (SD 1.9) post‐educational intervention (p < 0.0001, Table 2). Overall RAQ scores remained unchanged for the sample and among Filipino, Korean, and Hispanic/Latino American subgroups (Table 3A), the educational intervention had a positive impact on the research attitudes of attendees under 55 years old (Table 3B)Conclusion: Our findings indicate the potential effectiveness of culturally and linguistically tailored educational interventions in fostering increased awareness and knowledge of preclinical AD research among Filipino, Korean, and Hispanic/Latino Americans. However, this single intervention did not affect research attitudes overall or in different subgroups most relevant to the AHEAD 3‐45 trial (55 years and older), underscoring the need for additional tailored strategies to enhance representation in preclinical Alzheimer’s disease research.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Open AccessImprovement of Knowledge and Research Attitudes on Preclinical Alzheimer’s Disease Trials through Community‐based Education Among Underrepresented Korean, Filipino, and Hispanic Americans
Background: Racial and ethnic minorities, including Hispanic/Latino, Asian American and Pacific Islander individuals, lack adequate representation in preclinical Alzheimer’s disease (AD) trials. This study sought to examine the effectiveness of a culturally and linguistically appropriate community‐based educational intervention in enhancing knowledge and awareness of the AHEAD 3‐45 preclinical AD trial among underrepresented Filipino, Korean, and Hispanic/Latino Americans.Method: With professional nursing and other partner organizations, we conducted 21 community‐based educational sessions for underrepresented older adults of Filipino, Korean, and Hispanic/Latino backgrounds. In addition to sociodemographic data, we collected the 7‐item Research Attitude Questionnaire (RAQ; Range 7‐35) and a 6‐item Knowledge Questionnaire about the AHEAD 3‐45 preclinical AD trial (Range 0‐6) before and after the educational intervention. Pre‐ and post‐summary scores were generated for both assessments. Paired t‐tests assessed changes in research attitudes and knowledge concerning the AHEAD 3‐45 trial.Result: Among 654 attendees of the educational interventions, 472 (72%) completed surveys (Table 1). Most were women (77%), immigrants (83%), and had a primary language other than English (70%). The average age was 59 (16) years. Survey responses were obtained in English (41%), Spanish (29%), and Korean (30%). The primary motivations reported by attendees for attending the event were gaining information (48%) and concerns about memory loss for self and/or family members (41%).Knowledge of the AHEAD 3‐45 preclinical AD trial was significantly increased from a mean of 2.15 (SD 2.2) at baseline to 4.32 (SD 1.9) post‐educational intervention (p < 0.0001, Table 2). Overall RAQ scores remained unchanged for the sample and among Filipino, Korean, and Hispanic/Latino American subgroups (Table 3A), the educational intervention had a positive impact on the research attitudes of attendees under 55 years old (Table 3B)Conclusion: Our findings indicate the potential effectiveness of culturally and linguistically tailored educational interventions in fostering increased awareness and knowledge of preclinical AD research among Filipino, Korean, and Hispanic/Latino Americans. However, this single intervention did not affect research attitudes overall or in different subgroups most relevant to the AHEAD 3‐45 trial (55 years and older), underscoring the need for additional tailored strategies to enhance representation in preclinical Alzheimer’s disease research.
- Open Access
- 23 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (38) , e30301
Effectiveness of an integrative medicine approach to improve cognitive dysfunction and dementia: An observational study
Despite the urgent need to control dementia, an effective treatment has yet to be developed. Along with the Korean government’s policy of cooperation between conventional medicine (CM) and Korean medicine (KM), integrative medical services for dementia patients are being provided. This study aimed to compare the integrative medical clinic (IMC) for dementia used by Dongguk University Hospitals (DUH) with other service models and to review the characteristics and treatment outcomes of patients who had visited DUH over the past 5 years. Patients’ electronic medical records from May 2015 to June 2020 were searched and their data were analyzed to evaluate the IMC’s service model. Patient demographic and clinical characteristics, diagnostic tests, and treatment patterns for CM and KM were collected. The proportion of patients who did not show worsening cognitive function was described in detail. A strength of the DUH integrative medicine clinic is its ability to manage both KM and CM patients in the same space at the same time. Among the 82 patients who visited the clinic during our study period, 56 remained for data analysis after we excluded patients who met the exclusion criteria; nineteen patients had diagnoses of mild cognitive impairment. Among collaboration patterns, the first visit to the IMC had the highest proportion (55.4%). Among diagnosed tests in CM, laboratory tests and neuropsychological tests were used the most. In KM, a heart rate variability test was frequently used. The most common CM treatment prescribed was anticonvulsants, with 22 patients (39.2%) receiving donepezil, whereas the most frequent KM treatments were acupuncture (82.1%) and herbal medicine (78.6%). Twelve patients were followed up with the Mini-Mental State Examination, and 8 demonstrated either no worsening or improved cognition (baseline Mini-Mental State Examination range: 21–26). All 8 patients had mild cognitive impairment including 6 with amnestic, multidomain impairment. This study searched for a way to improve cognitive dysfunction and dementia using an integrative approach, and it shows promising results for mild cognitive impairment. However, more precisely designed follow-up studies are needed to address the present work’s limitations of a retrospective study design and a small sample size.
- 23 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (38) , e30301
Open AccessEffectiveness of an integrative medicine approach to improve cognitive dysfunction and dementia: An observational study
Despite the urgent need to control dementia, an effective treatment has yet to be developed. Along with the Korean government’s policy of cooperation between conventional medicine (CM) and Korean medicine (KM), integrative medical services for dementia patients are being provided. This study aimed to compare the integrative medical clinic (IMC) for dementia used by Dongguk University Hospitals (DUH) with other service models and to review the characteristics and treatment outcomes of patients who had visited DUH over the past 5 years. Patients’ electronic medical records from May 2015 to June 2020 were searched and their data were analyzed to evaluate the IMC’s service model. Patient demographic and clinical characteristics, diagnostic tests, and treatment patterns for CM and KM were collected. The proportion of patients who did not show worsening cognitive function was described in detail. A strength of the DUH integrative medicine clinic is its ability to manage both KM and CM patients in the same space at the same time. Among the 82 patients who visited the clinic during our study period, 56 remained for data analysis after we excluded patients who met the exclusion criteria; nineteen patients had diagnoses of mild cognitive impairment. Among collaboration patterns, the first visit to the IMC had the highest proportion (55.4%). Among diagnosed tests in CM, laboratory tests and neuropsychological tests were used the most. In KM, a heart rate variability test was frequently used. The most common CM treatment prescribed was anticonvulsants, with 22 patients (39.2%) receiving donepezil, whereas the most frequent KM treatments were acupuncture (82.1%) and herbal medicine (78.6%). Twelve patients were followed up with the Mini-Mental State Examination, and 8 demonstrated either no worsening or improved cognition (baseline Mini-Mental State Examination range: 21–26). All 8 patients had mild cognitive impairment including 6 with amnestic, multidomain impairment. This study searched for a way to improve cognitive dysfunction and dementia using an integrative approach, and it shows promising results for mild cognitive impairment. However, more precisely designed follow-up studies are needed to address the present work’s limitations of a retrospective study design and a small sample size.
- Open Access
- 8 July 2015
- Published by Wiley in Clinical and Translational Science
- Vol. 8 (5) , 445-450
Quantification of Aerosol Hydrofluoroalkane HFA‐134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration
Inhaled corticosteroids (ICS) and β2‐agonists are the primary pharmacotherapies of asthma management. However, suboptimal medication compliance is common in asthmatics and is associated with increased morbidity. We hypothesized that exhaled breath measurements of the aerosol used in the inhaled medications might prove useful as surrogate marker for asthma medication compliance. To explore this, 10 healthy controls were recruited and randomly assigned to ICS (Flovent HFA) or short acting bronchodilators (Proventil HFA). Both inhalers contain HFA‐134a as aerosol propellant. Exhaled breath sampling and pulmonary function tests were performed prior to the inhaler medication dispersion, immediately after inhalation, then at 2, 4, 6, 8, 24, and 48 hours postadministration. At baseline, mean (SD) levels of HFA‐134a in the breath were 252 (156) pptv. Immediately after inhalation, HFA‐134a breath levels increased to 300 × 106pptv and were still well above ambient levels 24 hours postadministration. The calculated ratio of forced expiratory volume in 1 second over forced vital capacity did not change over time following inhaler administration. This study demonstrates, for the first time, that breath HFA‐134a levels can be used to assess inhaler medication compliance. It may also be used to evaluate how effectively the medicine is delivered.
- 8 July 2015
- Published by Wiley in Clinical and Translational Science
- Vol. 8 (5) , 445-450
Open AccessQuantification of Aerosol Hydrofluoroalkane HFA‐134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration
Inhaled corticosteroids (ICS) and β2‐agonists are the primary pharmacotherapies of asthma management. However, suboptimal medication compliance is common in asthmatics and is associated with increased morbidity. We hypothesized that exhaled breath measurements of the aerosol used in the inhaled medications might prove useful as surrogate marker for asthma medication compliance. To explore this, 10 healthy controls were recruited and randomly assigned to ICS (Flovent HFA) or short acting bronchodilators (Proventil HFA). Both inhalers contain HFA‐134a as aerosol propellant. Exhaled breath sampling and pulmonary function tests were performed prior to the inhaler medication dispersion, immediately after inhalation, then at 2, 4, 6, 8, 24, and 48 hours postadministration. At baseline, mean (SD) levels of HFA‐134a in the breath were 252 (156) pptv. Immediately after inhalation, HFA‐134a breath levels increased to 300 × 106pptv and were still well above ambient levels 24 hours postadministration. The calculated ratio of forced expiratory volume in 1 second over forced vital capacity did not change over time following inhaler administration. This study demonstrates, for the first time, that breath HFA‐134a levels can be used to assess inhaler medication compliance. It may also be used to evaluate how effectively the medicine is delivered.
- Open Access
- 10 July 2013
- Published by Wiley in Clinical and Translational Medicine
- Vol. 2 (1) , 13
Gas signatures from Escherichia coli and Escherichia coli‐inoculated human whole blood
Background: The gaseous headspace above naïve Escherichia Coli (E. coli) cultures and whole human blood inoculated with E. coli were collected and analyzed for the presence of trace gases that may have the potential to be used as novel, non‐invasive markers of infectious disease.Methods: The naïve E. coli culture, LB broth, and human whole blood or E. coli inoculated whole blood were incubated in hermetically sealable glass bioreactors at 37°C for 24 hrs. LB broth and whole human blood were used as controls for background volatile organic compounds (VOCs). The headspace gases were collected after incubation and analyzed using a gas chromatographic system with multiple column/detector combinations.Results: Six VOCs were observed to be produced by E. coli‐infected whole blood while there existed nearly zero to relatively negligible amounts of these gases in the whole blood alone, LB broth, or E. coli‐ inoculated LB broth. These VOCs included dimethyl sulfide (DMS), carbon disulfide (CS2), ethanol, acetaldehyde, methyl butanoate, and an unidentified gas S. In contrast, there were several VOCs significantly elevated in the headspace above the E. coli in LB broth, but not present in the E. coli/blood mixture. These VOCs included dimethyl disulfide (DMDS), dimethyl trisulfide (DMTS), methyl propanoate, 1‐propanol, methylcyclohexane, and unidentified gases R2 and Q.Conclusions: This study demonstrates 1) that cultivated E. coli in LB broth produce distinct gas profiles, 2) for the first time, the ability to modify E. coli‐specific gas profiles by the addition of whole human blood, and 3) that E. coli‐human whole blood interactions present different gas emission profiles that have the potential to be used as non‐invasive volatile biomarkers of E. coli infection.
- 10 July 2013
- Published by Wiley in Clinical and Translational Medicine
- Vol. 2 (1) , 13
Open AccessGas signatures from Escherichia coli and Escherichia coli‐inoculated human whole blood
Background: The gaseous headspace above naïve Escherichia Coli (E. coli) cultures and whole human blood inoculated with E. coli were collected and analyzed for the presence of trace gases that may have the potential to be used as novel, non‐invasive markers of infectious disease.Methods: The naïve E. coli culture, LB broth, and human whole blood or E. coli inoculated whole blood were incubated in hermetically sealable glass bioreactors at 37°C for 24 hrs. LB broth and whole human blood were used as controls for background volatile organic compounds (VOCs). The headspace gases were collected after incubation and analyzed using a gas chromatographic system with multiple column/detector combinations.Results: Six VOCs were observed to be produced by E. coli‐infected whole blood while there existed nearly zero to relatively negligible amounts of these gases in the whole blood alone, LB broth, or E. coli‐ inoculated LB broth. These VOCs included dimethyl sulfide (DMS), carbon disulfide (CS2), ethanol, acetaldehyde, methyl butanoate, and an unidentified gas S. In contrast, there were several VOCs significantly elevated in the headspace above the E. coli in LB broth, but not present in the E. coli/blood mixture. These VOCs included dimethyl disulfide (DMDS), dimethyl trisulfide (DMTS), methyl propanoate, 1‐propanol, methylcyclohexane, and unidentified gases R2 and Q.Conclusions: This study demonstrates 1) that cultivated E. coli in LB broth produce distinct gas profiles, 2) for the first time, the ability to modify E. coli‐specific gas profiles by the addition of whole human blood, and 3) that E. coli‐human whole blood interactions present different gas emission profiles that have the potential to be used as non‐invasive volatile biomarkers of E. coli infection.
- Open Access
- 29 April 2009
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 7 (1) , 31
Acetaldehyde and hexanaldehyde from cultured white cells
Background: Noninvasive detection of innate immune function such as the accumulation of neutrophils remains a challenge in many areas of clinical medicine. We hypothesized that granulocytes could generate volatile organic compounds.Methods: To begin to test this, we developed a bioreactor and analytical GC-MS system to accurately identify and quantify gases in trace concentrations (parts per billion) emitted solely from cell/media culture. A human promyelocytic leukemia cell line, HL60, frequently used to assess neutrophil function, was grown in serum-free medium.Results: HL60 cells released acetaldehyde and hexanaldehyde in a time-dependent manner. The mean ± SD concentration of acetaldehyde in the headspace above the cultured cells following 4-, 24- and 48-h incubation was 157 ± 13 ppbv, 490 ± 99 ppbv, 698 ± 87 ppbv. For hexanaldehyde these values were 1 ± 0.3 ppbv, 8 ± 2 ppbv, and 11 ± 2 ppbv. In addition, our experimental system permitted us to identify confounding trace gas contaminants such as styrene.Conclusion: This study demonstrates that human immune cells known to mimic the function of innate immune cells, like neutrophils, produce volatile gases that can be measuredin vitroin trace amounts.
- 29 April 2009
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 7 (1) , 31
Open AccessAcetaldehyde and hexanaldehyde from cultured white cells
Background: Noninvasive detection of innate immune function such as the accumulation of neutrophils remains a challenge in many areas of clinical medicine. We hypothesized that granulocytes could generate volatile organic compounds.Methods: To begin to test this, we developed a bioreactor and analytical GC-MS system to accurately identify and quantify gases in trace concentrations (parts per billion) emitted solely from cell/media culture. A human promyelocytic leukemia cell line, HL60, frequently used to assess neutrophil function, was grown in serum-free medium.Results: HL60 cells released acetaldehyde and hexanaldehyde in a time-dependent manner. The mean ± SD concentration of acetaldehyde in the headspace above the cultured cells following 4-, 24- and 48-h incubation was 157 ± 13 ppbv, 490 ± 99 ppbv, 698 ± 87 ppbv. For hexanaldehyde these values were 1 ± 0.3 ppbv, 8 ± 2 ppbv, and 11 ± 2 ppbv. In addition, our experimental system permitted us to identify confounding trace gas contaminants such as styrene.Conclusion: This study demonstrates that human immune cells known to mimic the function of innate immune cells, like neutrophils, produce volatile gases that can be measuredin vitroin trace amounts.